Late-life depression symptom profiles are differentially associated with immunometabolic functioning
Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline asses...
Ausführliche Beschreibung
Autor*in: |
Vogelzangs, Nicole [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014transfer abstract |
---|
Schlagwörter: |
---|
Umfang: |
7 |
---|
Übergeordnetes Werk: |
Enthalten in: A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor - Al Naim, Abdullah F. ELSEVIER, 2022, Orlando, Fla. [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:41 ; year:2014 ; pages:109-115 ; extent:7 |
Links: |
---|
DOI / URN: |
10.1016/j.bbi.2014.05.004 |
---|
Katalog-ID: |
ELV022829784 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV022829784 | ||
003 | DE-627 | ||
005 | 20230625140152.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bbi.2014.05.004 |2 doi | |
028 | 5 | 2 | |a GBVA2014014000003.pica |
035 | |a (DE-627)ELV022829784 | ||
035 | |a (ELSEVIER)S0889-1591(14)00126-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 |a 150 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 150 |q DE-600 |
082 | 0 | 4 | |a 540 |q VZ |
084 | |a 35.00 |2 bkl | ||
084 | |a 51.50 |2 bkl | ||
084 | |a 58.00 |2 bkl | ||
100 | 1 | |a Vogelzangs, Nicole |e verfasserin |4 aut | |
245 | 1 | 0 | |a Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
264 | 1 | |c 2014transfer abstract | |
300 | |a 7 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. | ||
520 | |a Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. | ||
650 | 7 | |a Cohort study |2 Elsevier | |
650 | 7 | |a Depression |2 Elsevier | |
650 | 7 | |a Inflammation |2 Elsevier | |
650 | 7 | |a Metabolic syndrome |2 Elsevier | |
650 | 7 | |a Elderly |2 Elsevier | |
700 | 1 | |a Comijs, Hannie C. |4 oth | |
700 | 1 | |a Oude Voshaar, Richard C. |4 oth | |
700 | 1 | |a Stek, Max L. |4 oth | |
700 | 1 | |a Penninx, Brenda W.J.H. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Al Naim, Abdullah F. ELSEVIER |t A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |d 2022 |g Orlando, Fla. [u.a.] |w (DE-627)ELV008146462 |
773 | 1 | 8 | |g volume:41 |g year:2014 |g pages:109-115 |g extent:7 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.bbi.2014.05.004 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
936 | b | k | |a 51.50 |j Metallische Werkstoffe: Allgemeines |q VZ |
936 | b | k | |a 58.00 |j Chemische Technik: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 41 |j 2014 |h 109-115 |g 7 | ||
953 | |2 045F |a 610 |
author_variant |
n v nv |
---|---|
matchkey_str |
vogelzangsnicolecomijshanniecoudevoshaar:2014----:aeieersinypopoieaeifrnilysoitdihm |
hierarchy_sort_str |
2014transfer abstract |
bklnumber |
35.00 51.50 58.00 |
publishDate |
2014 |
allfields |
10.1016/j.bbi.2014.05.004 doi GBVA2014014000003.pica (DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 DE-627 ger DE-627 rakwb eng 610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Vogelzangs, Nicole verfasserin aut Late-life depression symptom profiles are differentially associated with immunometabolic functioning 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier Comijs, Hannie C. oth Oude Voshaar, Richard C. oth Stek, Max L. oth Penninx, Brenda W.J.H. oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:41 year:2014 pages:109-115 extent:7 https://doi.org/10.1016/j.bbi.2014.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 41 2014 109-115 7 045F 610 |
spelling |
10.1016/j.bbi.2014.05.004 doi GBVA2014014000003.pica (DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 DE-627 ger DE-627 rakwb eng 610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Vogelzangs, Nicole verfasserin aut Late-life depression symptom profiles are differentially associated with immunometabolic functioning 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier Comijs, Hannie C. oth Oude Voshaar, Richard C. oth Stek, Max L. oth Penninx, Brenda W.J.H. oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:41 year:2014 pages:109-115 extent:7 https://doi.org/10.1016/j.bbi.2014.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 41 2014 109-115 7 045F 610 |
allfields_unstemmed |
10.1016/j.bbi.2014.05.004 doi GBVA2014014000003.pica (DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 DE-627 ger DE-627 rakwb eng 610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Vogelzangs, Nicole verfasserin aut Late-life depression symptom profiles are differentially associated with immunometabolic functioning 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier Comijs, Hannie C. oth Oude Voshaar, Richard C. oth Stek, Max L. oth Penninx, Brenda W.J.H. oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:41 year:2014 pages:109-115 extent:7 https://doi.org/10.1016/j.bbi.2014.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 41 2014 109-115 7 045F 610 |
allfieldsGer |
10.1016/j.bbi.2014.05.004 doi GBVA2014014000003.pica (DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 DE-627 ger DE-627 rakwb eng 610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Vogelzangs, Nicole verfasserin aut Late-life depression symptom profiles are differentially associated with immunometabolic functioning 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier Comijs, Hannie C. oth Oude Voshaar, Richard C. oth Stek, Max L. oth Penninx, Brenda W.J.H. oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:41 year:2014 pages:109-115 extent:7 https://doi.org/10.1016/j.bbi.2014.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 41 2014 109-115 7 045F 610 |
allfieldsSound |
10.1016/j.bbi.2014.05.004 doi GBVA2014014000003.pica (DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 DE-627 ger DE-627 rakwb eng 610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Vogelzangs, Nicole verfasserin aut Late-life depression symptom profiles are differentially associated with immunometabolic functioning 2014transfer abstract 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier Comijs, Hannie C. oth Oude Voshaar, Richard C. oth Stek, Max L. oth Penninx, Brenda W.J.H. oth Enthalten in Elsevier Al Naim, Abdullah F. ELSEVIER A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor 2022 Orlando, Fla. [u.a.] (DE-627)ELV008146462 volume:41 year:2014 pages:109-115 extent:7 https://doi.org/10.1016/j.bbi.2014.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 51.50 Metallische Werkstoffe: Allgemeines VZ 58.00 Chemische Technik: Allgemeines VZ AR 41 2014 109-115 7 045F 610 |
language |
English |
source |
Enthalten in A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor Orlando, Fla. [u.a.] volume:41 year:2014 pages:109-115 extent:7 |
sourceStr |
Enthalten in A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor Orlando, Fla. [u.a.] volume:41 year:2014 pages:109-115 extent:7 |
format_phy_str_mv |
Article |
bklname |
Chemie: Allgemeines Metallische Werkstoffe: Allgemeines Chemische Technik: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Cohort study Depression Inflammation Metabolic syndrome Elderly |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
authorswithroles_txt_mv |
Vogelzangs, Nicole @@aut@@ Comijs, Hannie C. @@oth@@ Oude Voshaar, Richard C. @@oth@@ Stek, Max L. @@oth@@ Penninx, Brenda W.J.H. @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV008146462 |
dewey-sort |
3610 |
id |
ELV022829784 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022829784</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625140152.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bbi.2014.05.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014014000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022829784</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0889-1591(14)00126-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">150</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vogelzangs, Nicole</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Late-life depression symptom profiles are differentially associated with immunometabolic functioning</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cohort study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolic syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Elderly</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Comijs, Hannie C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oude Voshaar, Richard C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stek, Max L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Penninx, Brenda W.J.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Al Naim, Abdullah F. ELSEVIER</subfield><subfield code="t">A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor</subfield><subfield code="d">2022</subfield><subfield code="g">Orlando, Fla. [u.a.]</subfield><subfield code="w">(DE-627)ELV008146462</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:41</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:109-115</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bbi.2014.05.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.50</subfield><subfield code="j">Metallische Werkstoffe: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.00</subfield><subfield code="j">Chemische Technik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">41</subfield><subfield code="j">2014</subfield><subfield code="h">109-115</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Vogelzangs, Nicole |
spellingShingle |
Vogelzangs, Nicole ddc 610 ddc 150 ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
authorStr |
Vogelzangs, Nicole |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008146462 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 150 - Psychology 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl Late-life depression symptom profiles are differentially associated with immunometabolic functioning Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly Elsevier |
topic |
ddc 610 ddc 150 ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly |
topic_unstemmed |
ddc 610 ddc 150 ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly |
topic_browse |
ddc 610 ddc 150 ddc 540 bkl 35.00 bkl 51.50 bkl 58.00 Elsevier Cohort study Elsevier Depression Elsevier Inflammation Elsevier Metabolic syndrome Elsevier Elderly |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
h c c hc hcc v r c o vrc vrco m l s ml mls b w p bw bwp |
hierarchy_parent_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
hierarchy_parent_id |
ELV008146462 |
dewey-tens |
610 - Medicine & health 150 - Psychology 540 - Chemistry |
hierarchy_top_title |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008146462 |
title |
Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
ctrlnum |
(DE-627)ELV022829784 (ELSEVIER)S0889-1591(14)00126-3 |
title_full |
Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
author_sort |
Vogelzangs, Nicole |
journal |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
journalStr |
A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 100 - Philosophy & psychology 500 - Science |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
109 |
author_browse |
Vogelzangs, Nicole |
container_volume |
41 |
physical |
7 |
class |
610 150 610 DE-600 150 DE-600 540 VZ 35.00 bkl 51.50 bkl 58.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Vogelzangs, Nicole |
doi_str_mv |
10.1016/j.bbi.2014.05.004 |
dewey-full |
610 150 540 |
title_sort |
late-life depression symptom profiles are differentially associated with immunometabolic functioning |
title_auth |
Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
abstract |
Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. |
abstractGer |
Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. |
abstract_unstemmed |
Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
Late-life depression symptom profiles are differentially associated with immunometabolic functioning |
url |
https://doi.org/10.1016/j.bbi.2014.05.004 |
remote_bool |
true |
author2 |
Comijs, Hannie C. Oude Voshaar, Richard C. Stek, Max L. Penninx, Brenda W.J.H. |
author2Str |
Comijs, Hannie C. Oude Voshaar, Richard C. Stek, Max L. Penninx, Brenda W.J.H. |
ppnlink |
ELV008146462 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/j.bbi.2014.05.004 |
up_date |
2024-07-06T17:16:20.949Z |
_version_ |
1803850802477924352 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022829784</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625140152.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bbi.2014.05.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014014000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022829784</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0889-1591(14)00126-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">150</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vogelzangs, Nicole</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Late-life depression symptom profiles are differentially associated with immunometabolic functioning</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Growing evidence suggests immune and metabolic dysregulation among depressed persons, possibly restricted to specific subgroups. This study explores the association between depressive disorders and characteristics with immunometabolic functioning among older persons. Data are from the baseline assessment of the Netherlands Study of Depression in Older Persons, including 131 non-depressed and 358 depressed (6-month DSM-IV major depressive disorder) persons (60–93years). Immune (C-reactive protein, interleukin [IL]-6) and metabolic (waist circumference, triglycerides, high-density lipoprotein cholesterol, blood pressure, fasting glucose) factors were measured. Depression characteristics included severity, age of onset, symptom profile (atypical/melancholic) and antidepressant use. Depressed persons showed lower IL-6 levels compared with non-depressed persons. Depressed persons, except those with atypical depression, had lower waist circumference, lower glucose levels and scored lower on an overall index including all immunometabolic factors. Low waist circumference was more pronounced among those with less severe depression and those with a later age of onset, whom also had lower blood pressure levels. Atypical depression was associated with higher triglyceride levels. Antidepressant use was not clearly associated with immunometabolic functioning. To conclude, contrary to our expectations, we found overall immunometabolic downregulation in older depressed persons, in particular among those with less severe symptoms and those with late-life onset. However, persons with atypical depression presented with metabolic upregulation compared with other depressed persons. Taking depression symptom profiles into account is important when examining biological dysregulation in late-life depression.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cohort study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Depression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metabolic syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Elderly</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Comijs, Hannie C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oude Voshaar, Richard C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stek, Max L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Penninx, Brenda W.J.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Al Naim, Abdullah F. ELSEVIER</subfield><subfield code="t">A new poly(3,4-ethylenedioxythiophene)-poly (styrene sulfonate)/nickel oxide nanoparticles (PEDOT:PSS/NiO) thermoelectric system with a promising thermoelectric power factor</subfield><subfield code="d">2022</subfield><subfield code="g">Orlando, Fla. [u.a.]</subfield><subfield code="w">(DE-627)ELV008146462</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:41</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:109-115</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bbi.2014.05.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.50</subfield><subfield code="j">Metallische Werkstoffe: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.00</subfield><subfield code="j">Chemische Technik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">41</subfield><subfield code="j">2014</subfield><subfield code="h">109-115</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.400218 |